Adamis Pharmaceuticals Corp·5

Feb 12, 6:44 PM ET

Glover Eddie Wabern 5

5 · Adamis Pharmaceuticals Corp · Filed Feb 12, 2019

Insider Transaction Report

Form 5
Period: 2018-12-31
Glover Eddie Wabern
CEO of U.S. Compounding, Inc.
Transactions
  • Gift

    Common Stock

    2018-06-0441,666741,668 total

Documents

1 file
  • 5
    primary_01.xmlPrimary

    PRIMARY DOCUMENT